Herman Borghys

936 total citations
25 papers, 537 citations indexed

About

Herman Borghys is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Herman Borghys has authored 25 papers receiving a total of 537 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Physiology and 7 papers in Oncology. Recurrent topics in Herman Borghys's work include Alzheimer's disease research and treatments (8 papers), Drug Transport and Resistance Mechanisms (6 papers) and Computational Drug Discovery Methods (5 papers). Herman Borghys is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Drug Transport and Resistance Mechanisms (6 papers) and Computational Drug Discovery Methods (5 papers). Herman Borghys collaborates with scholars based in Belgium, United States and Sweden. Herman Borghys's co-authors include Lieven Baert, Gerben van ‘t Klooster, Marie‐Paule Bouche, Marc Mercken, Kaj Blennow, Bianca Van Broeck, Erik Portelius, Henrik Zetterberg, Ulf Andréasson and Mikael K. Gustavsson and has published in prestigious journals such as PLoS ONE, Biomaterials and Journal of Controlled Release.

In The Last Decade

Herman Borghys

22 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Herman Borghys Belgium 12 165 125 104 86 83 25 537
Anantha Ram Nookala United States 11 47 0.3× 234 1.9× 41 0.4× 44 0.5× 124 1.5× 13 606
Anas Najjar Palestinian Territory 8 30 0.2× 146 1.2× 53 0.5× 46 0.5× 12 0.1× 11 452
Puneet Sharma New Zealand 14 48 0.3× 385 3.1× 47 0.5× 297 3.5× 56 0.7× 22 913
Akiko Kiriyama Japan 13 19 0.1× 158 1.3× 47 0.5× 90 1.0× 36 0.4× 41 454
Abeer M. Al-Ghananeem United States 15 54 0.3× 197 1.6× 15 0.1× 303 3.5× 21 0.3× 35 739
Adeola Shobo South Africa 13 95 0.6× 106 0.8× 76 0.7× 20 0.2× 14 0.2× 24 355
Bushra Nabi India 14 25 0.2× 177 1.4× 28 0.3× 271 3.2× 25 0.3× 24 525
Saleha Rehman India 13 23 0.1× 135 1.1× 23 0.2× 218 2.5× 21 0.3× 20 402
Xia Hao Sweden 9 119 0.7× 236 1.9× 25 0.2× 10 0.1× 12 0.1× 21 579
K Santhi India 10 168 1.0× 219 1.8× 20 0.2× 395 4.6× 5 0.1× 22 912

Countries citing papers authored by Herman Borghys

Since Specialization
Citations

This map shows the geographic impact of Herman Borghys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herman Borghys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herman Borghys more than expected).

Fields of papers citing papers by Herman Borghys

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herman Borghys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herman Borghys. The network helps show where Herman Borghys may publish in the future.

Co-authorship network of co-authors of Herman Borghys

This figure shows the co-authorship network connecting the top 25 collaborators of Herman Borghys. A scholar is included among the top collaborators of Herman Borghys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herman Borghys. Herman Borghys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Daneshmand, Siamak, et al.. (2025). PENELOPE: TISSUE PENETRATION OF GEMCITABINE PHOSPHATE METABOLITES FOLLOWING TAR-200 ADMINISTRATION VS STANDARD INTRAVESICAL INSTILLATION IN MINIPIGS. Urologic Oncology Seminars and Original Investigations. 43(3). 48–48.
2.
3.
Cools, Frank, et al.. (2020). Use of the Actiwatch-Mini® in dog safety studies as an early indicator for drug-induced behavioural changes. Journal of Pharmacological and Toxicological Methods. 104. 106896–106896.
4.
Bischoff, François, Serge Pieters, Didier Berthelot, et al.. (2019). Design and synthesis of a novel series of cyanoindole derivatives as potent γ-secretase modulators. Bioorganic & Medicinal Chemistry Letters. 29(14). 1737–1745. 6 indexed citations
5.
Gijsen, Harrie J. M., Gregor J. Macdonald, Daniel Oehlrich, et al.. (2018). Optimization of 1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors Toward a Clinical Candidate. Journal of Medicinal Chemistry. 61(12). 5292–5303. 11 indexed citations
6.
Ito, Hisanori, Hidekuni Yamakawa, Kouhei Nishitomi, et al.. (2017). [P1–075]: PRECLINICAL MULTI‐SPECIES PHARMACOKINETIC/PHARMACODYNAMIC ANALYSIS OF THE ORAL BACE INHIBITOR JNJ‐54861911. Alzheimer s & Dementia. 13(7S_Part_5). 2 indexed citations
7.
Guillaume, Michel, Herman Borghys, L.L. de Zwart, et al.. (2016). Lipophilic nalmefene prodrugs to achieve a one-month sustained release. Journal of Controlled Release. 232. 196–202. 13 indexed citations
8.
Borghys, Herman, Bianca Van Broeck, Tom Jacobs, et al.. (2016). Young to Middle-Aged Dogs with High Amyloid-β Levels in Cerebrospinal Fluid are Impaired on Learning in Standard Cognition tests. Journal of Alzheimer s Disease. 56(2). 763–774. 23 indexed citations
9.
Sjödin, Simon, Marc Mercken, Henrik Zetterberg, et al.. (2015). APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment. Alzheimer s Research & Therapy. 7(1). 77–77. 8 indexed citations
10.
Bischoff, François, Didier Berthelot, Daniel Oehlrich, et al.. (2014). Anilinotriazoles as potent gamma secretase modulators. Bioorganic & Medicinal Chemistry Letters. 24(24). 5805–5813. 12 indexed citations
11.
Borghys, Herman, Tom Jacobs, Bianca Van Broeck, et al.. (2013). Comparison of Two Different Methods for Measurement of Amyloid-β Peptides in Cerebrospinal Fluid after BACE1 Inhibition in a Dog Model. Journal of Alzheimer s Disease. 38(1). 39–48. 7 indexed citations
12.
13.
Cools, Frank, et al.. (2013). A translational assessment of preclinical versus clinical tools for cardiac contractility measurement: Comparison of LV dP/dtmax with echocardiography in telemetry implanted beagle dogs. Journal of Pharmacological and Toxicological Methods. 68(1). e15–e16. 1 indexed citations
14.
Mattsson, Niklas, Lawrence Rajendran, Henrik Zetterberg, et al.. (2012). BACE1 Inhibition Induces a Specific Cerebrospinal Fluid β-Amyloid Pattern That Identifies Drug Effects in the Central Nervous System. PLoS ONE. 7(2). e31084–e31084. 54 indexed citations
15.
Borghys, Herman, Marianne Tuefferd, Bianca Van Broeck, et al.. (2012). A Canine Model to Evaluate Efficacy and Safety of γ-Secretase Inhibitors and Modulators. Journal of Alzheimer s Disease. 28(4). 809–822. 12 indexed citations
16.
Klooster, Gerben van ‘t, et al.. (2010). Pharmacokinetics and Disposition of Rilpivirine (TMC278) Nanosuspension as a Long-Acting Injectable Antiretroviral Formulation. Antimicrobial Agents and Chemotherapy. 54(5). 2042–2050. 159 indexed citations
17.
Baert, Lieven, Laurent Schueller, Y. Tardy, et al.. (2008). Development of an implantable infusion pump for sustained anti-HIV drug administration. International Journal of Pharmaceutics. 355(1-2). 38–44. 14 indexed citations
18.
Schueller, Laurent, Lieven Baert, Sophie Lachau‐Durand, et al.. (2007). Dog model with implanted pump to test boosters for antiretroviral medication. International Journal of Pharmaceutics. 355(1-2). 45–52. 2 indexed citations
19.
Eichenbaum, Gary, Joe Nguyen, Herman Borghys, et al.. (2006). Preclinical Assessment of the Feasibility of Applying Controlled Release Oral Drug Delivery to a Lead Series of Atypical Antipsychotics. Journal of Pharmaceutical Sciences. 95(4). 883–895. 3 indexed citations
20.
Verreck, Geert, Yufu Li, Qiang Zhang, et al.. (2004). Preparation and physicochemical characterization of biodegradable nerve guides containing the nerve growth agent sabeluzole. Biomaterials. 26(11). 1307–1315. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anantha Ram Nookala Breakdown of academic impact, for papers by Anas Najjar Breakdown of academic impact, for papers by Puneet Sharma Breakdown of academic impact, for papers by Akiko Kiriyama Breakdown of academic impact, for papers by Abeer M. Al-Ghananeem Breakdown of academic impact, for papers by Adeola Shobo Breakdown of academic impact, for papers by Bushra Nabi Breakdown of academic impact, for papers by Saleha Rehman Breakdown of academic impact, for papers by Xia Hao Breakdown of academic impact, for papers by K Santhi
Rankless by CCL
2026